113 related articles for article (PubMed ID: 18562760)
1. Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI.
Buijs M; Vossen JA; Hong K; Georgiades CS; Geschwind JF; Kamel IR
AJR Am J Roentgenol; 2008 Jul; 191(1):285-9. PubMed ID: 18562760
[TBL] [Abstract][Full Text] [Related]
2. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
[TBL] [Abstract][Full Text] [Related]
3. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
Mannelli L; Kim S; Hajdu CH; Babb JS; Taouli B
Eur J Radiol; 2013 Apr; 82(4):577-82. PubMed ID: 23246330
[TBL] [Abstract][Full Text] [Related]
4. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.
Vossen JA; Kamel IR; Buijs M; Liapi E; Georgiades CS; Hong K; Geschwind JF
J Comput Assist Tomogr; 2008; 32(3):347-52. PubMed ID: 18520535
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
[TBL] [Abstract][Full Text] [Related]
6. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.
Li Z; Bonekamp S; Halappa VG; Corona-Villalobos CP; Pawlik T; Bhagat N; Reyes D; Lai H; Geschwind JF; Kamel IR
Radiology; 2012 Jul; 264(1):97-109. PubMed ID: 22627602
[TBL] [Abstract][Full Text] [Related]
7. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
[TBL] [Abstract][Full Text] [Related]
8. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.
Yuan Z; Ye XD; Dong S; Xu LC; Xu XY; Liu SY; Xiao XS
Eur J Radiol; 2010 Jul; 75(1):e9-14. PubMed ID: 19540083
[TBL] [Abstract][Full Text] [Related]
9. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
[TBL] [Abstract][Full Text] [Related]
10. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
[TBL] [Abstract][Full Text] [Related]
11. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
[TBL] [Abstract][Full Text] [Related]
12. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.
Mannelli L; Kim S; Hajdu CH; Babb JS; Clark TW; Taouli B
AJR Am J Roentgenol; 2009 Oct; 193(4):1044-52. PubMed ID: 19770328
[TBL] [Abstract][Full Text] [Related]
13. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
Yu JS; Kim JH; Chung JJ; Kim KW
J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization with drug-eluting beads preloaded with irinotecan as a first-line approach in uveal melanoma liver metastases: tumor response and predictive value of diffusion-weighted MR imaging in five patients.
Venturini M; Pilla L; Agostini G; Cappio S; Losio C; Orsi M; Ratti F; Aldrighetti L; De Cobelli F; Del Maschio A
J Vasc Interv Radiol; 2012 Jul; 23(7):937-41. PubMed ID: 22720894
[TBL] [Abstract][Full Text] [Related]
15. Solitary fibrous tumor of the liver: magnetic resonance imaging evaluation and treatment with transarterial chemoembolization.
El-Khouli RH; Geschwind JF; Bluemke DA; Kamel IR
J Comput Assist Tomogr; 2008; 32(5):769-71. PubMed ID: 18830108
[TBL] [Abstract][Full Text] [Related]
16. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors.
Gupta S; Bedikian AY; Ahrar J; Ensor J; Ahrar K; Madoff DC; Wallace MJ; Murthy R; Tam A; Hwu P
Am J Clin Oncol; 2010 Oct; 33(5):474-80. PubMed ID: 19935383
[TBL] [Abstract][Full Text] [Related]
17. Visceral metastases from melanoma: findings on MR imaging.
Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
[TBL] [Abstract][Full Text] [Related]
18. Treatment of melanoma metastases confined to the liver and future perspectives.
Vahrmeijer AL; van de Velde CJ; Hartgrink HH; Tollenaar RA
Dig Surg; 2008; 25(6):467-72. PubMed ID: 19212119
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI of the liver-Interpretative pearls and pitfalls.
Culverwell AD; Sheridan MB; Guthrie JA; Scarsbrook AF
Clin Radiol; 2013 Apr; 68(4):406-14. PubMed ID: 22981728
[TBL] [Abstract][Full Text] [Related]
20. Imaging of ocular melanoma metastasis.
Balasubramanya R; Selvarajan SK; Cox M; Joshi G; Deshmukh S; Mitchell DG; O'Kane P
Br J Radiol; 2016 Sep; 89(1065):20160092. PubMed ID: 27168029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
